Genetic stratification of neuroblastoma for treatment tailoring. - Wikidata - awgldk - TriplyDB

Genetic stratification of neuroblastoma for treatment tailoring.

Genetic stratification of neuroblastoma for treatment tailoring.

http://www.wikidata.org/entity/Q37932545

about

Research progress of neuroblastoma related gene variations.Quantitative global and gene-specific promoter methylation in relation to biological properties of neuroblastomas.Defining 'medical necessity' in an age of personalised medicine: A view from Canada.Telomere Maintenance Mechanisms in Cancer.

P2860

Q33566987-CE94D412-3083-4CAB-8C80-A2B1264093C5 Q34416570-7B07B22C-C9A0-41D1-A8CC-84F1659FBC0B Q48069953-21A94FC3-6300-413C-A96C-811AA4B45785 Q55443450-2C283F2E-2F08-4B58-81F6-20B6E2EA2C77

P2860

Genetic stratification of neuroblastoma for treatment tailoring.

http://www.wikidata.org/entity/Q37932545

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Genetic stratification of neuroblastoma for treatment tailoring.

@en

Genetic stratification of neuroblastoma for treatment tailoring.

@nl

type

label

Genetic stratification of neuroblastoma for treatment tailoring.

@en

Genetic stratification of neuroblastoma for treatment tailoring.

@nl

prefLabel

Genetic stratification of neuroblastoma for treatment tailoring.

@en

Genetic stratification of neuroblastoma for treatment tailoring.

@nl

P1433

Q37932545-C80A52E6-1034-4BEB-8B7D-D22B06D9C541

P1476

Q37932545-FB34F0F3-3094-4CEC-B026-BD44583ED92B

P2093

Q37932545-1C0611CC-4AA6-40FB-8448-A16A219E8984

Q37932545-89368358-A9D5-430A-84F3-29267A3070B5

Q37932545-AEA523AC-374D-40F3-A7C5-FC9E9C2492E3

P2860

Q37932545-0391B594-6D21-4B4A-B47E-0F9972898284

Q37932545-080AACF4-CE61-4147-B071-25DA394E79BB

Q37932545-1078AC86-8063-4B2E-9E87-37E88DC413E7

Q37932545-14A965FD-4D8A-486D-82FF-5A2A52CA30C8

Q37932545-1B46D699-387B-439B-9831-311F552860FE

Q37932545-2688C4F2-5003-4621-9ACA-A4C07B84AD5B

Q37932545-29781931-B67F-48BC-B36C-634993ADA8CC

Q37932545-29AC0CD3-760F-4E64-A0A5-53AEFB08B142

Q37932545-2B62C10A-5278-45CC-BCAE-EC96C4A342C6

Q37932545-353850AF-76E7-43C6-AECD-109C74ADA300

P304

Q37932545-80FBE17A-B003-488B-92EE-005CE79D8F01

P31

Q37932545-F4DCEDF9-A1C5-4D17-97A4-C0C93F3B27DB

P356

Q37932545-9B527333-1F41-4A64-B3F2-5C956F453070

P407

Q37932545-56C55A43-46D9-4A20-AFFF-5C1D8FDCACC9

P433

Q37932545-CEDD3B01-6C24-42EF-A6E3-B308A41D5A9C

P478

Q37932545-BDA40AB3-07CD-4959-9F7A-CD7D7BB036E4

P577

Q37932545-A513734E-9A10-4E19-BEA3-2D8176084FF6

P698

Q37932545-3D4D4DD2-682C-4FE5-B66A-75A8F33503A1

P356

P1433

Future Oncology

P1476

Genetic stratification of neuroblastoma for treatment tailoring.

@en

P2093

Isaac Yaniv

http://www.w3.org/2001/XMLSchema#string

Marta Jeison

http://www.w3.org/2001/XMLSchema#string

Shifra Ash

http://www.w3.org/2001/XMLSchema#string

P2860

Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification

Identification of ALK as a major familial neuroblastoma predisposition gene

Activating mutations in ALK provide a therapeutic target in neuroblastoma.

Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays.

CADM1 is a strong neuroblastoma candidate gene that maps within a 3.72 Mb critical region of loss on 11q23

High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.

Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines.

High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset.

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.

2p24 Gain region harboring MYCN gene compared with MYCN amplified and nonamplified neuroblastoma: biological and clinical characteristics.

P304

1087-1099

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON.11.87

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21919696

http://www.w3.org/2001/XMLSchema#string